LIVIVO - Search results -

Search results

Result 1 - 10 of total 73

Search options

Article ; Online: Epidemiology of community-acquired pneumonia caused by S treptococcus pneumoniae in older adults: a narrative review.

Elias, Christelle / Nunes, Marta C / Saadatian-Elahi, Mitra

2024 Volume 37, Issue 2, Page(s) 144–153

Abstract: Purpose of review: This review covers updated perspectives on different aspects of pneumococcal community-acquired pneumonia (pCAP), including the epidemiology, clinical presentation, risk factors, antibiotic treatment, and existing preventive ... ...

Abstract	Purpose of review: This review covers updated perspectives on different aspects of pneumococcal community-acquired pneumonia (pCAP), including the epidemiology, clinical presentation, risk factors, antibiotic treatment, and existing preventive strategies in older adults. Recent findings: pCAP remains the most prevalent condition among lower respiratory tract infections in the older adults according to Global Burden of Diseases 2019. Older adults can display atypical symptoms such as confusion, general clinical deterioration, new onset of and exacerbation of underlying illness that might trigger clinical suspicion of pCAP. Older adults with pCAP often experience increased disease severity and a higher risk of pulmonary complications compared with younger individuals, owing to age-related changes in immunity and a higher prevalence of comorbidities. Vaccination stands fundamental for prevention, emphasizing the need for effective immunization strategies, specifically tailored for older adults. There is a pressing need to reinforce efforts aimed at boosting pneumococcal vaccination rates. Summary: Despite a high morbidity and mortality, the burden of pCAP, in particular hospital admission and occurrence of invasive infections, among the elderly population is not sufficiently documented. This review findings emphasize the substantial burden of pCAP in this vulnerable population, driven by factors such as advancing age and underlying comorbidities. The emergence of antibiotic-resistant pneumococcal strains further complicates treatment decisions and highlights the importance of tailored approaches for managing pCAP in older adults.
MeSH term(s)	Humans ; Aged ; Pneumonia, Pneumococcal/epidemiology ; Pneumonia, Pneumococcal/prevention & control ; Streptococcus pneumoniae ; Respiratory Tract Infections/epidemiology ; Hospitalization ; Comorbidity ; Community-Acquired Infections/epidemiology ; Community-Acquired Infections/prevention & control ; Pneumococcal Vaccines ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control
Chemical Substances	Pneumococcal Vaccines
Language	English
Publishing date	2024-02-05
Publishing country	United States
Document type	Review ; Journal Article
ZDB-ID	645085-4
ISSN	1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
ISSN (online)	1473-6527 ; 1535-3877
ISSN	0951-7375 ; 1355-834X
DOI	10.1097/QCO.0000000000001005
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2462: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (2.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.

Details ▾
- See ZB MED holdings
- Order with fees

Article: Venerable but Vulnerable: When Centenarians Encounter Coronavirus Disease 2019.

Dessemon, Juliette / Elias, Christelle / Henaff, Laetitia / Saadatian-Elahi, Mitra / Vanhems, Philippe

Open forum infectious diseases

2022 Volume 9, Issue 1, Page(s) ofab580

Language	English
Publishing date	2022-01-09
Publishing country	United States
Document type	Journal Article
ZDB-ID	2757767-3
ISSN	2328-8957
ISSN	2328-8957
DOI	10.1093/ofid/ofab580
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Epidemiology and serotype distribution of

Sanchez Picot, Valentina / Keovichith, Inthalaphone / Paboriboune, Phimpha / Flaissier, Bruno / Saadatian-Elahi, Mitra / Rudge, James W

Frontiers in public health

2023 Volume 11, Page(s) 1124016

Abstract: Background: Data on the epidemiology of : Methods: Active ILI surveillance was conducted through weekly phone calls in an open community-based cohort study (April 2015-February 2019), involving 5,690 participants from 1,142 randomly selected ... ...

Abstract	Background: Data on the epidemiology of Methods: Active ILI surveillance was conducted through weekly phone calls in an open community-based cohort study (April 2015-February 2019), involving 5,690 participants from 1,142 randomly selected households. Participants reporting ILI symptoms provided a nasopharyngeal swab and answered a questionnaire. Results: Among 1,621 ILI episodes, 269 (16.6%) tested positive for nasopharyngeal pneumococcal carriage, with the highest prevalence (55.4%) in children under 5 years. Pneumococcal carriage was significantly associated with concurrent detection of Conclusions: Community-based surveillance of
MeSH term(s)	Infant ; Child ; Humans ; Child, Preschool ; Aged ; Streptococcus pneumoniae ; Serogroup ; Cohort Studies ; Pneumococcal Infections/epidemiology ; Pneumococcal Infections/prevention & control ; Influenza, Human ; Laos/epidemiology ; Carrier State/epidemiology ; Vaccines, Conjugate/pharmacology
Chemical Substances	Vaccines, Conjugate
Language	English
Publishing date	2023-04-20
Publishing country	Switzerland
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	2711781-9
ISSN	2296-2565 ; 2296-2565
ISSN (online)	2296-2565
ISSN	2296-2565
DOI	10.3389/fpubh.2023.1124016
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Patient influenza vaccination reduces the risk of hospital-acquired influenza: an incident test negative-case control study in Lyon university hospital, France (2004-2020)

Saadatian-Elahi, Mitra / Henaff, Laetitia / Elias, Christelle / Nunes, Marta C. / Hot, Arnaud / Martin-Gaujard, Géraldine / Escuret, Vanessa / Amour, Selilah / Vanhems, Philippe

Vaccine.

2023

Abstract: Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nested in a surveillance program aimed at evaluating the effectiveness of influenza vaccination in reducing ...

Abstract	Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nested in a surveillance program aimed at evaluating the effectiveness of influenza vaccination in reducing the risk of HAI in hospitalized patients during 15 influenza seasons (2004-05 to 2019-20). HAI cases were those who developed influenza like illness (ILI) symptoms at least 72h after hospitalization and had a positive reverse transcriptase-polymerase chain reaction (RT-PCR). Controls were those with ILI symptoms and a negative RT-PCR test. A nasal swab as well as socio-demographic, clinical data and information on influenza vaccination were collected. Of the 296 patients included, 67 were confirmed HAI cases. Influenza vaccine coverage was significantly higher among controls compared to HAI cases (p=0.002). The risk of HAI was reduced by almost 60% in vaccinated patients. A better control of HAI can be achieved by vaccinating hospitalized patients.
Keywords	case-control studies ; hospitals ; influenza ; influenza vaccination ; influenza vaccines ; monitoring ; nose ; patients ; reverse transcriptase polymerase chain reaction ; risk ; France ; Hospital-acquired ; Vaccine ; Surveillance
Publishing place	Elsevier Ltd
Document type	Article ; Online
Note	Pre-press version
ZDB-ID	605674-x
ISSN	1873-2518 ; 0264-410X
ISSN (online)	1873-2518
ISSN	0264-410X
DOI	10.1016/j.vaccine.2023.05.060
Database	NAL-Catalogue (AGRICOLA)

In stock of ZB MED Cologne/Königswinter

Zs.A 1930: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 458: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon, France.

Saadatian-Elahi, Mitra / Amour, Sélilah / Elias, Christelle / Henaff, Laetitia / Dananché, Cédric / Vanhems, Philippe

Journal of medical virology

2021 Volume 93, Issue 12, Page(s) 6822–6827

Abstract: Information gathered so far from published studies attest the existence of a complex relationship between tobacco smoking and the severity of COVID-19. We investigated the association between smoking habits and the severity of COVID-19 in patients ... ...

Abstract	Information gathered so far from published studies attest the existence of a complex relationship between tobacco smoking and the severity of COVID-19. We investigated the association between smoking habits and the severity of COVID-19 in patients hospitalized in university-affiliated hospitals in Lyon, France. Baseline sociodemographic, clinical and biological characteristics of adult COVID-19 hospitalized patients presenting from the community were prospectively collected and analyzed. Tobacco exposure was documented at admission. Characteristics of patients hospitalized in medical wards to those admitted or transferred to intensive care units (ICUs) were compared using Mann-Whitney and Χ
MeSH term(s)	Aged ; Aged, 80 and over ; COVID-19/pathology ; COVID-19/virology ; Female ; France ; Hospitalization ; Hospitals, University ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Odds Ratio ; Prospective Studies ; Smoking/adverse effects ; Tobacco Smoking/adverse effects
Language	English
Publishing date	2021-08-10
Publishing country	United States
Document type	Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	752392-0
ISSN	1096-9071 ; 0146-6615
ISSN (online)	1096-9071
ISSN	0146-6615
DOI	10.1002/jmv.27233
Database	MEDical Literature Analysis and Retrieval System OnLINE

Full text online

Accessible to users with ZB MED library card

In stock of ZB MED Cologne/Königswinter

Zs.A 1320: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾

Article ; Online: Baseline clinical features of COVID-19 patients, delay of hospital admission and clinical outcome: A complex relationship.

Dananché, Cédric / Elias, Christelle / Hénaff, Laetitia / Amour, Sélilah / Kuczewski, Elisabetta / Gustin, Marie-Paule / Escuret, Vanessa / Saadatian-Elahi, Mitra / Vanhems, Philippe

PloS one

2022 Volume 17, Issue 1, Page(s) e0261428

Abstract: Introduction: Delay between symptom onset and access to care is essential to prevent clinical worsening for different infectious diseases. For COVID-19, this delay might be associated with the clinical prognosis, but also with the different ... ...

Abstract	Introduction: Delay between symptom onset and access to care is essential to prevent clinical worsening for different infectious diseases. For COVID-19, this delay might be associated with the clinical prognosis, but also with the different characteristics of patients. The objective was to describe characteristics and symptoms of community-acquired (CA) COVID-19 patients at hospital admission according to the delay between symptom onset and hospital admission, and to identify determinants associated with delay of admission. Methods: The present work was based on prospective NOSO-COR cohort data, and restricted to patients with laboratory confirmed CA SARS-CoV-2 infection admitted to Lyon hospitals between February 8 and June 30, 2020. Long delay of hospital admission was defined as ≥6 days between symptom onset and hospital admission. Determinants of the delay between symptom onset and hospital admission were identified by univariate and multiple logistic regression analysis. Results: Data from 827 patients were analysed. Patients with a long delay between symptom onset and hospital admission were younger (p<0.01), had higher body mass index (p<0.01), and were more frequently admitted to intensive care unit (p<0.01). Their plasma levels of C-reactive protein were also significantly higher (p<0.01). The crude in-hospital fatality rate was lower in this group (13.3% versus 27.6%), p<0.01. Multiple analysis with correction for multiple testing showed that age ≥75 years was associated with a short delay between symptom onset and hospital admission (≤5 days) (aOR: 0.47 95% CI (0.34-0.66)) and CRP>100 mg/L at admission was associated with a long delay (aOR: 1.84 95% CI (1.32-2.55)). Discussion: Delay between symptom onset and hospital admission is a major issue regarding prognosis of COVID-19 but can be related to multiple factors such as individual characteristics, organization of care and severe pathogenic processes. Age seems to play a key role in the delay of access to care and the disease prognosis.
MeSH term(s)	Aged ; Aged, 80 and over ; COVID-19/epidemiology ; COVID-19/metabolism ; Cohort Studies ; Female ; France/epidemiology ; Hospitalization/trends ; Hospitals ; Humans ; Intensive Care Units ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Risk Factors ; SARS-CoV-2/metabolism ; SARS-CoV-2/pathogenicity ; Time-to-Treatment/trends
Language	English
Publishing date	2022-01-07
Publishing country	United States
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ISSN	1932-6203
ISSN (online)	1932-6203
DOI	10.1371/journal.pone.0261428
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Inter-library loan at ZB MED

Your chosen title can be delivered directly to ZB MED Cologne location if you are registered as a user at ZB MED Cologne.

Article ; Online: Addressing the COVID-19 pandemic challenges for operational adaptations of a cluster randomized controlled trial on dengue vector control in Malaysia.

Saadatian-Elahi, Mitra / Alexander, Neal / Möhlmann, Tim / Ariffin, Farah Diana / Schmitt, Frederic / Richardson, Jason H / Rabilloud, Muriel / Hamid, Nurulhusna Ab

BMC public health

2022 Volume 22, Issue 1, Page(s) 667

Abstract: Introduction: The COVID-19 pandemic placed an unprecedented overload on healthcare system globally. With all medical resources being dedicated to contain the spread of the disease, the pandemic may have impacted the burden of other infectious diseases ... ...

Abstract	Introduction: The COVID-19 pandemic placed an unprecedented overload on healthcare system globally. With all medical resources being dedicated to contain the spread of the disease, the pandemic may have impacted the burden of other infectious diseases such as dengue, particularly in countries endemic for dengue fever. Indeed, the co-occurrence of COVID-19 made dengue diagnosis challenging because of some shared clinical manifestations between the two pathogens. Furthermore, the sudden emergence and novelty of this global public health crisis has forced the suspension or slow-down of several research trials due to the lack of sufficient knowledge on how to handle the continuity of research trials during the pandemic. We report on challenges we have faced during the COVID-19 pandemic and measures that were implemented to continue the iDEM project (intervention for Dengue Epidemiology in Malaysia). Methods: This randomized controlled trial aims to assess the effectiveness of Integrated Vector Management (IVM) on the incidence of dengue in urban Malaysia by combining: targeted outdoor residual spraying (TORS), deployment of auto-dissemination devices (ADDs), and active community engagement (CE). Our operational activities started on February 10, 2020, a few weeks before the implementation of non-pharmaceutical interventions to contain the spread of COVID-19 in Malaysia. Results: The three main issues affecting the continuity of the trial were: ensuring the safety of field workers during the interventions; ensuring the planned turnover of TORS application and ADD deployment and services; and maintaining the CE activities as far as possible. Conclusions: Even though the pandemic has created monumental challenges, we ensured the safety of field workers by providing complete personal protective equipment and regular COVID-19 testing. Albeit with delay, we maintained the planned interval time between TORS application and ADDs services by overlapping the intervention cycles instead of having them in a sequential scheme. CE activities continued remotely through several channels (e.g., phone calls and text messages). Sustained efforts of the management team, significant involvement of the Malaysian Ministry of Health and a quick and smart adaptation of the trial organisation according to the pandemic situation were the main factors that allowed the successful continuation of our research. Trial registration: Trial registration number: ISRCTN-81915073 . Date of registration: 17/04/2020, 'Retrospectively registered'.
MeSH term(s)	COVID-19/epidemiology ; COVID-19 Testing ; Dengue/epidemiology ; Dengue/prevention & control ; Humans ; Malaysia/epidemiology ; Pandemics/prevention & control
Language	English
Publishing date	2022-04-06
Publishing country	England
Document type	Journal Article ; Randomized Controlled Trial ; Research Support, Non-U.S. Gov't
ZDB-ID	2041338-5
ISSN	1471-2458 ; 1471-2458
ISSN (online)	1471-2458
ISSN	1471-2458
DOI	10.1186/s12889-022-13026-x
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Diabetes as a risk factor for herpes zoster in adults: A synthetic literature review.

Saadatian-Elahi, Mitra / Bauduceau, Bernard / Del-Signore, Corinne / Vanhems, Philippe

Diabetes research and clinical practice

2019 Volume 159, Page(s) 107983

Abstract: Aim: The objective of this review was to evaluate the role of diabetes as a risk factor for herpes zoster (HZ) and to discuss implications of prevention by vaccination with available HZ vaccines.: Methods: We reviewed studies that investigated the ... ...

Abstract	Aim: The objective of this review was to evaluate the role of diabetes as a risk factor for herpes zoster (HZ) and to discuss implications of prevention by vaccination with available HZ vaccines. Methods: We reviewed studies that investigated the incidence rates of HZ in patients with diabetes. Papers in English or French published between January 2000 and December 2018 have been selected from PubMed and Google Scholarship by using appropriate key words. Results: The risk of HZ was significantly higher in patients with diabetes as compared to controls in 11 studies out of 16, although the magnitude of risk associated to diabetes varied across studies from 1.06 to 2.38 (p < 0.05). The incidence of HZ in patients with diabetes increased with age and was higher in women than in men. The incidence of the most common complication of HZ, i.e. post-herpetic neuralgia was also higher in patients with diabetes. Conclusions: The presence of HZ adds supplementary complications to the pre-existing comorbidity in patients with diabetes. Investigating the impact of preventive measure by HZ vaccination is therefore of paramount importance in patients with diabetes.
MeSH term(s)	Adult ; Diabetes Complications/complications ; Diabetes Complications/epidemiology ; Diabetes Complications/therapy ; Diabetes Complications/virology ; Diabetes Mellitus/epidemiology ; Female ; Herpes Zoster/epidemiology ; Herpes Zoster/etiology ; Herpes Zoster/therapy ; Herpes Zoster Vaccine/therapeutic use ; Herpesvirus 3, Human/physiology ; Humans ; Incidence ; Male ; Neuralgia, Postherpetic/therapy ; Risk Factors ; Vaccination/methods
Chemical Substances	Herpes Zoster Vaccine
Language	English
Publishing date	2019-12-14
Publishing country	Ireland
Document type	Journal Article ; Review
ZDB-ID	632523-3
ISSN	1872-8227 ; 0168-8227
ISSN (online)	1872-8227
ISSN	0168-8227
DOI	10.1016/j.diabres.2019.107983
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 2047: Show issues

Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular
Jg. 1995 - 2021: Lesesall (1.OG)
ab Jg. 2022: Lesesaal (EG)

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

Article ; Online: Factors Associated with Long COVID-19 in a French Multicentric Prospective Cohort Study.

Khanafer, Nagham / Henaff, Laetitia / Bennia, Sabrina / Termoz, Anne / Chapurlat, Roland / Escuret, Vanessa / Proriol, Mathilde / Duvert, Florence / Mena, Camille / Planckaert, Catherine / Trehet-Mandez, Nadège / Saadatian-Elahi, Mitra / Vanhems, Philippe

International journal of environmental research and public health

2023 Volume 20, Issue 17

Abstract: 1) Background: A substantial proportion of COVID-19 patients continue to experience long-lasting effects that hamper their quality of life. The objectives of this study were (1) to report the prevalence of persistent clinical symptoms 6-12 months after ... ...

Abstract	(1) Background: A substantial proportion of COVID-19 patients continue to experience long-lasting effects that hamper their quality of life. The objectives of this study were (1) to report the prevalence of persistent clinical symptoms 6-12 months after the onset of COVID-19 and (2) to identify potential factors at admission associated with the occurrence of long COVID. (2) Methods: A prospective study was conducted among COVID-19 adult patients, hospitalized in four French university hospitals. Patients were invited to two ambulatory follow-up medical visits, 6-8 months (visit #1) and one year (visit #2) after the onset of their COVID-19. A multivariate logistic regression was performed to assess factors associated with long COVID. (3) Results: In total, 189 patients participated in this study (mean age of 63.4 years). BMI > 30 kg/m
MeSH term(s)	Adult ; Humans ; Middle Aged ; Post-Acute COVID-19 Syndrome ; Prospective Studies ; COVID-19/epidemiology ; Quality of Life ; Ageusia
Language	English
Publishing date	2023-08-29
Publishing country	Switzerland
Document type	Journal Article
ZDB-ID	2175195-X
ISSN	1660-4601 ; 1661-7827
ISSN (online)	1660-4601
ISSN	1661-7827
DOI	10.3390/ijerph20176678
Database	MEDical Literature Analysis and Retrieval System OnLINE

Order via subito

Article ; Online: Patient influenza vaccination reduces the risk of hospital-acquired influenza: An incident test negative-case control study in Lyon university hospital, France (2004-2020).

Saadatian-Elahi, Mitra / Henaff, Laetitia / Elias, Christelle / Nunes, Marta C / Hot, Arnaud / Martin-Gaujard, Géraldine / Escuret, Vanessa / Amour, Selilah / Vanhems, Philippe

Vaccine

2023 Volume 41, Issue 30, Page(s) 4341–4346

Abstract: Background: Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nested in a surveillance program aimed at evaluating the effectiveness of influenza ... ...

Abstract	Background: Literature is limited on the impact of patient vaccination on the risk of hospital-acquired influenza (HAI). This test negative case-control study nested in a surveillance program aimed at evaluating the effectiveness of influenza vaccination in reducing the risk of HAI in hospitalized patients during 15 influenza seasons (2004-05 to 2019-20). Methods: HAI cases were those who developed influenza like illness (ILI) symptoms at least 72 h after hospitalization and had a positive reverse transcriptase-polymerase chain reaction (RT-PCR). Controls were those with ILI symptoms and a negative RT-PCR test. A nasal swab as well as socio-demographic, clinical data and information on influenza vaccination were collected. Results: Of the 296 patients included, 67 were confirmed HAI cases. Influenza vaccine coverage was significantly higher among controls compared to HAI cases (p = 0.002). The risk of HAI was reduced by almost 60 % in vaccinated patients. Conclusions: A better control of HAI can be achieved by vaccinating hospitalized patients.
MeSH term(s)	Humans ; Case-Control Studies ; France/epidemiology ; Hospitalization ; Hospitals, University ; Influenza Vaccines ; Influenza, Human/epidemiology ; Influenza, Human/prevention & control ; Seasons ; Vaccination
Chemical Substances	Influenza Vaccines
Language	English
Publishing date	2023-06-14
Publishing country	Netherlands
Document type	Journal Article ; Research Support, Non-U.S. Gov't
ZDB-ID	605674-x
ISSN	1873-2518 ; 0264-410X
ISSN (online)	1873-2518
ISSN	0264-410X
DOI	10.1016/j.vaccine.2023.05.060
Database	MEDical Literature Analysis and Retrieval System OnLINE

In stock of ZB MED Cologne/Königswinter

Zs.A 1930: Show issues			Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG)
Zs.MO 458: Show issues

Order via subito

Details ▾
- See ZB MED holdings
- Order with fees

To top

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

Full text online

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

Inter-library loan at ZB MED

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito

More links

Kategorien

Order via subito

More links

Kategorien

In stock of ZB MED Cologne/Königswinter

Order via subito